Dr. David Berman’s appointment as Head of the Department of Pathology & Molecular Medicine will end on June 30, 2026. In accordance with the Senate document governing the Appointment of Heads of Clinical/Academic Departments that was approved on March 26, 2009, a joint Headship Search Committee for the Department of Pathology & Molecular Medicine is to be established. The role of the Committee is to provide advice to the Provost and Vice-Principal (Academic) of Queen’s University and to the Board Chairs of the participating hospitals on the present state and future prospects of the Department, and to make a recommendation on its future leadership.
In applying the process, Queen’s Health Sciences is consulting widely, through correspondence, with members of the Department’s faculty and staff, students, residents, members of the teaching hospitals, and other members of the university and health sciences communities, as appropriate.
We invite you to submit your comments on the present state and future prospects of the Department of Pathology & Molecular Medicine and the degree of support for Dr. Berman’s reappointment as Head. Submissions may be made via the linked .
While submissions will be accepted throughout the process, it will be advantageous for the committee to have them by September 26, 2025. Please note that anonymous submissions will not be considered; however, names and identifiable information will be removed from responses prior to being shared with the Modified Reappointment Committee.